If you have reached therapeutic metformin doses (1,5002,000 mg/day) and your blood sugar control remains suboptimal or weight loss has stalled, stepping up to a GLP-1 receptor agonist is a standard clinical decision supported by American Diabetes Association guidelines
Final Thought GLP-1s can be a powerful accelerator for weight lossbut without the right nutritional and lifestyle foundation, they may leave people metabolically worse off in the long run
Prioritizing adequate sleep, managing stress through mindfulness or relaxation techniques, and engaging in regular moderate exercise are crucial
Tang received research grant support from Abbott Laboratories, and served as consultants for Medtronic Inc and St
Other possible side effects include decreased appetite, headache, and fatigue